Targeted drugs work differently from chemotherapy drugs and often have different side effects. Like chemotherapy, these drugs enter the bloodstream and reach almost all areas of the body, which makes them useful against cancers that have spread to distant parts of the body. Targeted drugs sometimes work even when chemo drugs do not. Some targeted drugs can help other types of treatment work better. Targeted therapy for HER2-positive breast cancer In about 1 in 5 women with breast cancer, the cancer cells have too much of a growth-promoting protein known as HER2 on their surface.
Emerging Areas in Metastatic Breast Cancer Treatment
Emerging Areas in Metastatic Breast Cancer Treatment | Susan G. Komen®
Chemotherapy is one of the most powerful tools we have to treat cancer, and research continues to find new chemotherapy drugs as well as new uses for existing ones. At the same time, newer types of drugs are being developed that work in different ways to attack cancer cells. Before any new drug can be sold in the United States, it goes through an approval process. The FDA also provides doctors and patients with information about how to use the new drug safely. In , the FDA approved several new drug treatments for different cancer types that American Cancer Society editors believe will make a significant difference.
CAR-T, which stands for chimeric antigen receptor T-cell therapy, uses T cells from taken from your blood and genetically alters them to attack cancer. The modified cells are given back to you by infusion. CAR-T therapies do carry risks.
Many new treatments for metastatic breast cancer are under study and treatment is improving. Findings from clinical trials will determine whether or not new treatments will become a part of standard care for metastatic breast cancer. Some treatments may even go on to be used for early stage breast cancer care. Learn about clinical trials for people with metastatic breast cancer and access a web-based personalized clinical trial matching tool - the Metastatic Trial Search.